Intas Pharmaceuticals Limited Methotrexate Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Methotrexate Export Records India — #3 Exporter, 109 Shipments, $1.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Methotrexate

India Pharmaceutical Trade Intelligence

$34.9M353 Suppliers148 CountriesHS 30049042

ExportsIndia → UNITED KINGDOM29.6%India → UNITED STATES16.3%

ImportsUNITED STATES → India$53.1K GERMANY → India$5.5K

#1 Supplier: CIPLA LIMITED #1 Buyer: ALLOGA UK

Intas Pharmaceuticals Limited — Methotrexate Exporter #3 | $1.5M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Methotrexate Exporter Profile

Indian Pharmaceutical Exporter · #3 for Methotrexate · $1.5M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #3 Indian exporter of Methotrexate with $1.5M in export value and 109 verified shipments. Intas Pharmaceuticals Limited holds a 4.4% market share in Methotrexate exports across 11 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Methotrexate Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Methotrexate export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Methotrexate?

Country	Value	Shipments	Share
CANADA	$901.0K	32	51.6%
MEXICO	$578.7K	17	33.1%
AUSTRALIA	$122.6K	6	7.0%
NETHERLANDS	$50.7K	19

Who Are the Top Buyers of Methotrexate from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
ACCORD HEALTHCARE INC	CANADA	$463.4K	13
ACCORD FARMA S.A. DE C.V.	MEXICO	$311.9K	10
ACCORD HEALTHCARE INC.	CANADA	$250.5K	12
ACCORD FARMA S A DE C V	MEXICO	$131.6K	4
XXCORXXHEAXXHCAXX INXX	CANADA	$120.6K	3
TO THE ORDER.	MEXICO	$85.1K	2
TO THE ORDER	SPAIN	$76.4K	13
ACCORD HEALTHCARE PTY LIMITED	AUSTRALIA	$65.8K	3
ACCORD HEALTHCARE PTY LTD	AUSTRALIA	$56.8K	3
ACCORD FARMA S.A.DE C.V	MEXICO	$50.0K	1

Intas Pharmaceuticals Limited supplies Methotrexate to 29 buyers globally. The largest buyer is ACCORD HEALTHCARE INC (CANADA), followed by ACCORD FARMA S.A. DE C.V. (MEXICO) and ACCORD HEALTHCARE INC. (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Methotrexate Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
METHOTREXATE 50MG/ML, 0.50ML 1PFSAC-CAN	$140.9K	3
PHARMA. DRUGS & MEDICINE TRAXACORD 2 ML(25MG/ML 2ML) METHOTREXATE INJ. BP25MG/ML(2ML)	$124.6K	3
PHARMA DRUGS AND MEDI TRAXACORD 2 ML (25MG/ML, 2ML) METHOTREXATE INJECTION BP 25MG/ML(2ML) EACH ML CONTAINS: METHOTREXATNOS	$89.3K	3
PH.DRU.& MED TRAXACORD 2 ML (25mg/ml, 2ml) METHOTREXATE INJECTION BP 25MG/ML(2ML) EACH ML CONT.METHOTREXATE PH. EUR.25MG	$85.1K	2
METHOTREXATE 50MG/ML 0.50ML 1PFS(AC-CAN	$70.6K	2
PHARMA.DRUGS & MEDICINE METHOTREXATE INJECTION BP-25MG/ML-40ML EACH ML CONTS. METHOTREXATE PH.EUR.25MG WATER FOR INJ.	$61.9K	2
PHARMA DRUGS & MEDI: METHOTREXATE INJECT	$55.9K	3
METHOTREXATE 50MG/ML 0.30ML 1PFS(AC-CAN	$50.0K	1
METHOTREXATE 50MG/ML, 0.35ML 1PFSAC-CAN	$50.0K	1
METHOTREXATE 50MG/ML, 0.45ML 1PFSAC-CAN	$50.0K	1

Intas Pharmaceuticals Limited exports 91 distinct Methotrexate formulations including tablets, capsules, syrups, and combination drugs. The top formulation is METHOTREXATE 50MG/ML, 0.50ML 1PFSAC-CAN with 3 shipments worth $140.9K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Methotrexate Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	CIPLA LIMITED	$10.8M	217	13	$50.0K
2	EUGIA PHARMA SPECIALITIES LIMITED	$2.9M	58	3	$50.0K
3	INTAS PHARMACEUTICALS LIMITED ★	$1.5M	109	11	$14.0K
6	NAPROD LIFE SCIENCES PRIVATE LIMITED	$1.2M	45	8	$25.6K
4	ZYDUS LIFESCIENCES LIMITED	$950.0K	19	2	$50.0K

Intas Pharmaceuticals Limited ranks #3 among 353 Indian Methotrexate exporters. Average shipment value of $14.0K compared to the market average of $60.3K. The closest competitors by value are CIPLA LIMITED and EUGIA PHARMA SPECIALITIES LIMITED.

Which Indian Ports Ship Methotrexate Exports?

Port	Shipments	% Share
SAHAR AIR	890	23.4%
SAHAR AIR CARGO ACC (INBOM4)	719	18.9%
DELHI AIR CARGO ACC (INDEL4)	415	10.9%
DELHI AIR	267	7.0%
Bombay Air	239	6.3%
NHAVA SHEVA SEA (INNSA1)	148	3.9%
HYDERABAD AIR	89	2.3%
Bombay Air Cargo	80	2.1%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Methotrexate Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Methotrexate shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 118 individual customs records matching Intas Pharmaceuticals Limited exporting Methotrexate, covering 91 formulations to 11 countries via 29 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 148+ countries, 879+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Methotrexate

Methotrexate

Intas Pharmaceuticals Limited — Methotrexate Exporter Profile

Intas Pharmaceuticals Limited — Methotrexate Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Methotrexate?

Who Are the Top Buyers of Methotrexate from Intas Pharmaceuticals Limited?

What Is India's Total Methotrexate Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Methotrexate Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Methotrexate Exporters?

What Methotrexate Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Methotrexate to Key Markets

Canada — HC

Mexico — COFEPRIS

Australia — TGA

How Does Intas Pharmaceuticals Limited Compare to Nearest Methotrexate Exporters?

Which Indian Ports Ship Methotrexate Exports?

Methotrexate — Export Intelligence Video

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Methotrexate Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Methotrexate Export Data from Intas Pharmaceuticals Limited

Methotrexate Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source